True play attitudes and behaviors in intercollegiate athletes : a thesis ...

This thesis investigated the attitudes and the behaviors in the main sport environment of 53 intercollegiate athletes. Two instruments were developed, administered, and combined to give three measures of the true play characteristics of the subjects who were members of the men\u27s golf, men\u27s basketball, men\u27s tennis, women\u27s basketball, women\u27s tennis and women\u27s volleyball teams at the University of the Pacific. Results were determined by using the Statistical Package for the Social Sciences: Update 7-9. ANOVA and Scheffe\u27s post hoc test revealed, at the .05 level, that female athletes scored higher in true play characteristics than did male athletes; that star athletes scored higher in true play characteristics than did regular and substitute athletes; and that the sport of volleyball scored higher in true play characteristics than did the sport of golf

Out of sight but not out of mind: Home countries’ macroeconomic volatilities and immigrants’ mental health

We provide the first empirical evidence that better economic performances by immigrants’ countries of origin, as measured by lower CPI or higher GDP, improve immigrants’ mental health. We use an econometrically-robust approach that exploits exogenous changes in macroeconomic conditions across immigrants’ home countries over time and controls for immigrants’ observable and unobservable characteristics. The CPI effect is statistically significant and sizeable. Furthermore, the CPI effect diminishes as the time since emigrating increases. By contrast, home countries’ unemployment rates and exchange rate fluctuations have no impact on immigrants’ mental health

A critical review of the evidence for M32 being a compact dwarf satellite of M31 rather than a more distant normal galaxy

Since Baade's photographic study of M32 in the mid 1940s, it has been accepted as an established fact that M32 is a compact dwarf satellite of M31. The purpose of this paper is to report on the findings of our investigation into the nature of the existing evidence. We find that the case for M32 being a satellite of M31 rests upon Hubble Space Telescope (HST) based stellar population studies which have resolved red-giant branch (RGB) and red clump stars in M32 as well as other nearby galaxies. Taken in isolation, this recent evidence could be considered to be conclusive in favour of the existing view. However, the conventional scenario does not explain M32's anomalously high central velocity dispersion for a dwarf galaxy (several times that of either NGC 147, NGC 185 or NGC 205) or existing planetary nebula observations (which suggest that M32 is more than twice as distant as M31) and also requires an elaborate physical explanation for M32's inferred compactness. Conversely, we find that the case for M32 being a normal galaxy, of the order of three times as distant as M31, is supported by: (1) a central velocity dispersion typical of intermediate galaxies, (2) the published planetary nebula observations, and (3) known scaling relationships for normal early-type galaxies. However, this novel scenario cannot account for the high apparent luminosities of the RGB stars resolved in the M32 direction by HST observations. We are therefore left with two apparently irreconcilable scenarios, only one of which can be correct, but both of which suffer from potentially fatal evidence to the contrary. This suggests that current understanding of some relevant fields is still very far from adequate.Comment: 17 pages, 3 Postscript figures, uses cjaa.cls and natbib.sty (published version has 16 pages

The twilight of the Liberal Social Contract? On the Reception of Rawlsian Political Liberalism

This chapter discusses the Rawlsian project of public reason, or public justification-based 'political' liberalism, and its reception. After a brief philosophical rather than philological reconstruction of the project, the chapter revolves around a distinction between idealist and realist responses to it. Focusing on political liberalism’s critical reception illuminates an overarching question: was Rawls’s revival of a contractualist approach to liberal legitimacy a fruitful move for liberalism and/or the social contract tradition? The last section contains a largely negative answer to that question. Nonetheless the chapter's conclusion shows that the research programme of political liberalism provided and continues to provide illuminating insights into the limitations of liberal contractualism, especially under conditions of persistent and radical diversity. The programme is, however, less receptive to challenges to do with the relative decline of the power of modern states

Constitutivism

A brief explanation and overview of constitutivism

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist

Philosophy of action

The philosophical study of human action begins with Plato and Aristotle. Their influence in late antiquity and the Middle Ages yielded sophisticated theories of action and motivation, notably in the works of Augustine and Aquinas.1 But the ideas that were dominant in 1945 have their roots in the early modern period, when advances in physics and mathematics reshaped philosophy

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570